7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Reference - Treatment ... removed in septic shock ... follow up cultures required ... of metastatic infection ... #Treatment #Management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... With or Without Bacteremia ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Purtilo (XLP) Acquired ... CMV, HHV8,...), Bacteria ... Histoplasmosis, candidiasis ... Unknown cause Treatment ... diagnosis #management #treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile Infection ... Toxic Megacolon, Shock ... can be community-acquired ... Tx Management (IDSA ... Ileus, Megacolon, Shock
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... : • The best treatment ... Microsporidiosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... Peliosis Hepatis, Bacteremia ... Bartonellosis #IDSA ... #Prevention #Treatment ... #management #opportunistic